TY - JOUR AU - Brandt, L. J. AU - Chey, W. D. AU - Foxx-Orenstein, A. E. AU - Schiller, L. R. AU - Schoenfeld, P. S. PY - 2009 DA - 2009// TI - An evidence-based position statement on the management of irritable bowel syndrome JO - Am J Gastroenterol VL - 104 ID - Brandt2009 ER - TY - JOUR AU - Saito, Y. A. AU - Schoenfeld, P. AU - Locke, G. R. PY - 2002 DA - 2002// TI - The epidemiology of irritable bowel syndrome in North America: a systematic review JO - Am J Gastroenterol VL - 97 ID - Saito2002 ER - TY - JOUR AU - Hungin, A. P. AU - Chang, L. AU - Locke, G. R. AU - Dennis, E. H. AU - Barghout, V. PY - 2005 DA - 2005// TI - Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact JO - Aliment Pharmacol Ther VL - 21 UR - https://doi.org/10.1111/j.1365-2036.2005.02463.x DO - 10.1111/j.1365-2036.2005.02463.x ID - Hungin2005 ER - TY - JOUR AU - Quigley, E. M. AU - Bytzer, P. AU - Jones, R. AU - Mearin, F. PY - 2006 DA - 2006// TI - Irritable bowel syndrome: the burden and unmet needs in Europe JO - Dig Liver Dis VL - 38 UR - https://doi.org/10.1016/j.dld.2006.05.009 DO - 10.1016/j.dld.2006.05.009 ID - Quigley2006 ER - TY - JOUR AU - Lovell, R. M. AU - Ford, A. C. PY - 2012 DA - 2012// TI - Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis JO - Clin Gastroenterol Hepatol VL - 10 UR - https://doi.org/10.1016/j.cgh.2012.02.029 DO - 10.1016/j.cgh.2012.02.029 ID - Lovell2012 ER - TY - JOUR AU - Dean, B. B. AU - Aguilar, D. AU - Barghout, V. AU - Kahler, K. H. AU - Frech, F. AU - Groves, D. PY - 2005 DA - 2005// TI - Impairment in work productivity and health-related quality of life in patients with IBS JO - Am J Manag Care VL - 11 ID - Dean2005 ER - TY - JOUR AU - El-Serag, H. B. AU - Olden, K. AU - Bjorkman, D. PY - 2002 DA - 2002// TI - Health-related quality of life among persons with irritable bowel syndrome: a systematic review JO - Aliment Pharmacol Ther VL - 16 UR - https://doi.org/10.1046/j.1365-2036.2002.01290.x DO - 10.1046/j.1365-2036.2002.01290.x ID - El-Serag2002 ER - TY - JOUR AU - Everhart, J. E. AU - Ruhl, C. E. PY - 2009 DA - 2009// TI - Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases JO - Gastroenterology VL - 136 UR - https://doi.org/10.1053/j.gastro.2008.12.015 DO - 10.1053/j.gastro.2008.12.015 ID - Everhart2009 ER - TY - JOUR AU - Camilleri, M. PY - 2001 DA - 2001// TI - Management of the irritable bowel syndrome JO - Gastroenterology VL - 120 UR - https://doi.org/10.1053/gast.2001.21908 DO - 10.1053/gast.2001.21908 ID - Camilleri2001 ER - TY - JOUR AU - Talley, N. J. AU - Gabriel, S. E. AU - Harmsen, W. S. AU - Zinsmeister, A. R. AU - Evans, R. W. PY - 1995 DA - 1995// TI - Medical costs in community subjects with irritable bowel syndrome JO - Gastroenterology VL - 109 UR - https://doi.org/10.1016/0016-5085(95)90738-6 DO - 10.1016/0016-5085(95)90738-6 ID - Talley1995 ER - TY - JOUR AU - Hirata, T. AU - Keto, Y. AU - Nakata, M. AU - Takeuchi, A. AU - Funatsu, T. AU - Akuzawa, S. PY - 2008 DA - 2008// TI - Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer JO - Neurogastroenterol Motil VL - 20 UR - https://doi.org/10.1111/j.1365-2982.2007.01069.x DO - 10.1111/j.1365-2982.2007.01069.x ID - Hirata2008 ER - TY - JOUR AU - Humphrey, P. P. AU - Bountra, C. AU - Clayton, N. AU - Kozlowski, K. PY - 1999 DA - 1999// TI - Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome JO - Aliment Pharmacol Ther VL - 13 ID - Humphrey1999 ER - TY - JOUR AU - Camilleri, M. AU - Northcutt, A. R. AU - Kong, S. AU - Dukes, G. E. AU - McSorley, D. AU - Mangel, A. W. PY - 2000 DA - 2000// TI - Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02033-X DO - 10.1016/S0140-6736(00)02033-X ID - Camilleri2000 ER - TY - JOUR AU - Andresen, V. AU - Montori, V. M. AU - Keller, J. AU - West, C. P. AU - Layer, P. AU - Camilleri, M. PY - 2008 DA - 2008// TI - Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials JO - Clin Gastroenterol Hepatol VL - 6 UR - https://doi.org/10.1016/j.cgh.2007.12.015 DO - 10.1016/j.cgh.2007.12.015 ID - Andresen2008 ER - TY - JOUR AU - Cremonini, F. AU - Nicandro, J. P. AU - Atkinson, V. AU - Shringarpure, R. AU - Chuang, E. AU - Lembo, A. PY - 2012 DA - 2012// TI - Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS JO - Aliment Pharmacol Ther VL - 36 UR - https://doi.org/10.1111/j.1365-2036.2012.05208.x DO - 10.1111/j.1365-2036.2012.05208.x ID - Cremonini2012 ER - TY - JOUR AU - Cremonini, F. AU - Delgado-Aros, S. AU - Camilleri, M. PY - 2003 DA - 2003// TI - Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials JO - Neurogastroenterol Motil VL - 15 UR - https://doi.org/10.1046/j.1365-2982.2003.00389.x DO - 10.1046/j.1365-2982.2003.00389.x ID - Cremonini2003 ER - TY - JOUR AU - Jones, R. H. AU - Holtmann, G. AU - Rodrigo, L. AU - Ehsanullah, R. S. AU - Crompton, P. M. AU - Jacques, L. A. PY - 1999 DA - 1999// TI - Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients JO - Aliment Pharmacol Ther VL - 13 UR - https://doi.org/10.1046/j.1365-2036.1999.00678.x DO - 10.1046/j.1365-2036.1999.00678.x ID - Jones1999 ER - TY - JOUR AU - Friedel, D. AU - Thomas, R. AU - Fisher, R. S. PY - 2001 DA - 2001// TI - Ischemic colitis during treatment with alosetron JO - Gastroenterology VL - 120 UR - https://doi.org/10.1053/gast.2001.21177 DO - 10.1053/gast.2001.21177 ID - Friedel2001 ER - TY - JOUR AU - Fujii, Y. AU - Saitoh, Y. AU - Tanaka, H. AU - Toyooka, H. PY - 1999 DA - 1999// TI - Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy JO - Can J Anaesth VL - 46 UR - https://doi.org/10.1007/BF03013138 DO - 10.1007/BF03013138 ID - Fujii1999 ER - TY - JOUR AU - Shi, Y. AU - He, X. AU - Yang, S. AU - Ai, B. AU - Zhang, C. AU - Huang, D. PY - 2007 DA - 2007// TI - Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: a prospective randomized controlled study JO - Chemotherapy VL - 53 UR - https://doi.org/10.1159/000098418 DO - 10.1159/000098418 ID - Shi2007 ER - TY - JOUR AU - Kim, H. J. AU - Shin, S. W. AU - Song, E. K. AU - Lee, N. R. AU - Kim, J. S. AU - Ahn, J. S. PY - 2015 DA - 2015// TI - Ramosetron versus Ondansetron in combination with Aprepitant and Dexamethasone for the prevention of highly Emetogenic chemotherapy-induced nausea and vomiting: a multicenter, randomized phase III trial, KCSG PC10-21 JO - Oncologist VL - 20 UR - https://doi.org/10.1634/theoncologist.2015-0128 DO - 10.1634/theoncologist.2015-0128 ID - Kim2015 ER - TY - JOUR AU - Fukudo, S. AU - Ida, M. AU - Akiho, H. AU - Nakashima, Y. AU - Matsueda, K. PY - 2014 DA - 2014// TI - Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea JO - Clin Gastroenterol Hepatol VL - 12 UR - https://doi.org/10.1016/j.cgh.2013.11.024 DO - 10.1016/j.cgh.2013.11.024 ID - Fukudo2014 ER - TY - JOUR AU - Fukudo, S. AU - Kinoshita, Y. AU - Okumura, T. AU - Ida, M. AU - Akiho, H. AU - Nakashima, Y. PY - 2016 DA - 2016// TI - Ramosetron reduces symptoms of irritable bowel syndrome with Diarrhea and improves quality of life in women JO - Gastroenterology VL - 150 UR - https://doi.org/10.1053/j.gastro.2015.10.047 DO - 10.1053/j.gastro.2015.10.047 ID - Fukudo2016 ER - TY - JOUR AU - Lee, K. J. AU - Kim, N. Y. AU - Kwon, J. K. AU - Huh, K. C. AU - Lee, O. Y. AU - Lee, J. S. PY - 2011 DA - 2011// TI - Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine JO - Neurogastroenterol Motil VL - 23 UR - https://doi.org/10.1111/j.1365-2982.2011.01771.x DO - 10.1111/j.1365-2982.2011.01771.x ID - Lee2011 ER - TY - JOUR AU - Matsueda, K. AU - Harasawa, S. AU - Hongo, M. AU - Hiwatashi, N. AU - Sasaki, D. PY - 2008 DA - 2008// TI - A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome JO - Scand J Gastroenterol VL - 43 UR - https://doi.org/10.1080/00365520802240255 DO - 10.1080/00365520802240255 ID - Matsueda2008 ER - TY - JOUR AU - Matsueda, K. AU - Harasawa, S. AU - Hongo, M. AU - Hiwatashi, N. AU - Sasaki, D. PY - 2008 DA - 2008// TI - A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome JO - Digestion VL - 77 UR - https://doi.org/10.1159/000150632 DO - 10.1159/000150632 ID - Matsueda2008 ER - TY - STD TI - Higgins JPT, Sally Green. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook-5-1.cochrane.org/. UR - http://handbook-5-1.cochrane.org/ ID - ref27 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gotzsche, P. C. AU - Ioannidis, J. P. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b2700 DO - 10.1136/bmj.b2700 ID - Liberati2009 ER - TY - JOUR AU - Sterne, J. A. AU - Sutton, A. J. AU - Ioannidis, J. P. AU - Terrin, N. AU - Jones, D. R. AU - Lau, J. PY - 2011 DA - 2011// TI - Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d4002 DO - 10.1136/bmj.d4002 ID - Sterne2011 ER - TY - JOUR AU - Ford, A. C. AU - Moayyedi, P. AU - Lacy, B. E. AU - Lembo, A. J. AU - Saito, Y. A. AU - Schiller, L. R. PY - 2014 DA - 2014// TI - American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation JO - Am J Gastroenterol VL - 109 UR - https://doi.org/10.1038/ajg.2014.187 DO - 10.1038/ajg.2014.187 ID - Ford2014 ER - TY - JOUR AU - Fukudo, S. AU - Kinoshita, Y. AU - Okumura, T. AU - Ida, M. AU - Hayashi, K. AU - Akiho, H. PY - 2016 DA - 2016// TI - Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study JO - J Gastroenterol VL - 51 UR - https://doi.org/10.1007/s00535-016-1165-5 DO - 10.1007/s00535-016-1165-5 ID - Fukudo2016 ER - TY - JOUR AU - Suh, D. C. AU - Kahler, K. H. AU - Choi, I. S. AU - Shin, H. AU - Kralstein, J. AU - Shetzline, M. PY - 2007 DA - 2007// TI - Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis JO - Aliment Pharmacol Ther VL - 25 UR - https://doi.org/10.1111/j.1365-2036.2007.03250.x DO - 10.1111/j.1365-2036.2007.03250.x ID - Suh2007 ER - TY - JOUR AU - Camilleri, M. AU - Mayer, E. A. AU - Drossman, D. A. AU - Heath, A. AU - Dukes, G. E. AU - McSorley, D. PY - 1999 DA - 1999// TI - Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist JO - Aliment Pharmacol Ther VL - 13 UR - https://doi.org/10.1046/j.1365-2036.1999.00610.x DO - 10.1046/j.1365-2036.1999.00610.x ID - Camilleri1999 ER - TY - JOUR AU - Chang, L. AU - Heitkemper, M. M. PY - 2002 DA - 2002// TI - Gender differences in irritable bowel syndrome JO - Gastroenterology VL - 123 UR - https://doi.org/10.1053/gast.2002.36603 DO - 10.1053/gast.2002.36603 ID - Chang2002 ER -